Recent Bans of Textured Implants & Polynovo to Stop BIA ALCL?, page-23

I will if you want KS, I reckon I actually got the first one right?
Do you need more info? because as far as I know the FY21 starts starts in July 2020 and ends in June 2021, s the SP will rise to the occasion well before they are on the market, of that I have no doubt! but early FY2021 that puts my guestimation in the ballpark!
I was going on the information that was out there already not something that was released later, but even looking at the latest info, it looks as though I was somewhere in the ballpark?

The earlier release talks about Calendar Year and the latest release talk about the Financial Year.

Surely EARLY FY2021 is in the second half of the Calendar Year CY2020? isn't that around August or so?


https://quoteapi.com/resources/da98...n_and_CEO_Address_to_Shareholders.pdf?embed=1

The product pipeline looks exciting. Our Hernia product development has progressed, and we are in the process of purchasing production machinery to manufacture the product. We anticipate market entry in 2H CY20. This Hernia product has the ability to take PolyNovo to another level.

https://hotcopper.com.au/documentdownload?id=uOMxKKzFkiWRTLKhOROKAxjvSTYP4Qy8zhCZsPlvke92GA==

The new Hernia products have progressed to commercial scale up.
PolyNovo purchased the adjacent factory which will enable the building of the plant and equipment for commercial manufacture of these devices.
We have filed additional patents for the NovoSorb family of products.

PolyNovo had very strong initial commercial success with NovoSorb BTM and there are significant and tangible sales opportunities ahead.
We are well advanced in our Hernia repair device development and anticipate US market entry in early FY21.
The factory build, fit out and validation processes will be a major task for the year ahead